Clinical Care Options commentary: Jasvinder Singh provides expert guidance on the use of newer biologic and targeted synthetic DMARDs as monotherapy for rheumatoid arthritis.
Expert physician, nurse, and pharmacist views on using monotherapy to treat rheumatoid arthritis are provided in this CME/CE/CPE-certified video.
Expert commentary from Roy Fleischmann, MD, on when to select biologic or targeted synthetic DMARD monotherapy for treating rheumatoid arthritis.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.